News
Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data
Shares of Moderna fell almost 20% after a leak suggested issues with its experimental cancer vaccine data.
More News
- Nasdaq, S&P 500 Slide Amid Tech Sell-Off; Treasury Yields Plunge
- Gen Z Is Starting Businesses at a Record Pace
- The "American Dream" Now Costs More Than $5 Million in Texas
- For More Families, Child Care Costs As Much As A Mortgage
- New Student Loan Forgiveness Rule Scrapped After the Education Department Backs Down in Legal Fight